Patient Characteristics (n = 13)
| Characteristic | Data |
| Age (y) | 68 (50–78) |
| Sex | |
| Male | 11 (85%) |
| Female | 2 (15%) |
| Primary malignancy | |
| Hepatocellular carcinoma | 10 (77%) |
| Metastatic colorectal carcinoma | 3 (23%) |
| Treatment | |
| Lobar | 11 (85%) |
| Right | 11 (85%) |
| Left | 0 (0%) |
| Superselective | 2 (15%) |
| Administered 90Y activity (GBq) | 2.58 (1.17–7.11) |
| Time from 90Y calibration to treatment (d)† | 9 (2–11) |
| Estimated administered microspheres (n × 106)† | 4.81 (1.71–13.8) |
| Average absorbed 90Y dose (Gy) | |
| Treated part | 102.9 (71.8–125.3) |
| Functional parenchyma | 83.4 (71.6–117.0) |
| Tumor | 174.3 (66.7–335.8) |
| Time from HBS-pre to treatment (d) | 26 (10–64) |
| Time from treatment to HBS-post (d) | 92 (58–111) |
| Cirrhosis | 6 (46%) |
| Portal hypertension | 4 (31%) |
↵† n = 8.
Continuous data are median followed by range in parentheses. Categoric data are frequency followed by percentage in parentheses.